基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I am a consultant general surgeon with a subspecialty interests in upper GI and soft tissue sarcoma surgery. I hold a full-time substantive consultant post at the Queen Elizabeth Hospital, Birmingham and together with two colleagues deliver a high volume quaternary specialist sarcoma service MARSU (Midlands Abdominal and Retroperitoneal Sarcoma Unit).
I commenced appointment as a substantive consultant surgeon in January 2016 following advanced fellowships in soft tissue sarcoma surgery in Birmingham and Milan. My main area of expertise is the management of soft tissue sarcoma and I have built up considerable experience of performing complex, extended multi-visceral operations for sarcoma throughout the abdominal cavity, pelvis, pelvic girdle and retroperitoneum. In addition, I support the supra-regional RPLND service for testicular cancers and perform specialist surgery for gastrointestinal neuroendocrine tumours (NET) and gastrointestinal stromal tumours (GIST). Sarcoma surgery provides unrivalled exposure to anatomy of the retroperitoneum and otherwise rarely performed operative maneuvers and familiarity with handling the great vessels.
I am a key member of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group, bringing together the World’s Specialist Sarcoma Units as a collaborative approach to developing international consensus guidelines on the management of sarcoma. I have coordinated a collaborative effort to derive international guidelines for the management of schwannoma and contributed to the development of specialist consensus guidelines for primary, recurrent and metastatic retroperitoneal sarcoma.
I am Chief Investigator for a proposed national RCT for NETs, randomising patients with stage IV SI-NET to up-front surgery versus active surveillance to assess the impact on overall survival and quality of life. This RCT is adopted by the Cancer Research UK Clinical Trials Unit and is being prepared for HTA funding rounds in September 2021.
I am the Chief Investigator for an intercontinental collaborative RCT (SARveillance) to prospectively investigate the intensity of post resection surveillance in sarcoma and the impact on overall survival. The trial is adopted by the Cancer Research UK Clinical Trials Unit and is being prepared for HTA funding rounds in Jan 2022.
I am the Principal Investigator for ROSSINI II RCT Trial for the reduction of thirty day surgical site infection in elective and emergency patients in conjunction with the Birmingham Clinical Trials Unit.
I currently supervise two PhD students at the University of Birmingham.
I have authored multiple peer reviewed articles in the management of sarcoma, NET, GIST and upper GI cancers.
研究兴趣
论文共 76 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mark Fairweather, Megan L. Sulciner,Joshua S. Jolissaint,Marco Fiore, Dorian Yarih Garcia Ortega,Carol Swallow,Samuel Ford,Shintaro Iwata,Eran Nizri,Vittorio Quagliuolo, Dagmar Adamkova,Carolyn Nessim,
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S40-S41
引用0浏览0引用
0
0
ANNALS OF SURGICAL ONCOLOGY (2023)
European Journal of Surgical Oncologyno. 2 (2023): e34-e35
CURRENT ONCOLOGYno. 3 (2023): 2781-2791
BMJ OPENno. 5 (2023): e070327-e070327
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncologyno. 11 (2023): 107085-107085
Mei Sien Liew,Fabio Tirotta, Sivesh Kamarajah,Marco Baia,Alessandro Parente,Anant Desai,Samuel J. Ford, Tan Benjamin,Max L. Almond
European Journal of Surgical Oncologyno. 2 (2023): e172-e172
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn